Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Change in Cash: 2017-2024

Historic Change in Cash for Solid Biosciences (SLDB) over the last 8 years, with Dec 2024 value amounting to $15.9 million.

  • Solid Biosciences' Change in Cash fell 36.50% to $15.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year increase of 107.79%. This contributed to the annual value of $6.3 million for FY2024, which is 107.79% up from last year.
  • Per Solid Biosciences' latest filing, its Change in Cash stood at $15.9 million for Q4 2024, which was up 150.45% from -$31.4 million recorded in Q3 2024.
  • Over the past 5 years, Solid Biosciences' Change in Cash peaked at $129.9 million during Q4 2020, and registered a low of -$90.9 million during Q3 2021.
  • In the last 3 years, Solid Biosciences' Change in Cash had a median value of $1.9 million in 2022 and averaged -$3.3 million.
  • As far as peak fluctuations go, Solid Biosciences' Change in Cash soared by 1,035.32% in 2022, and later tumbled by 670.37% in 2023.
  • Over the past 5 years, Solid Biosciences' Change in Cash (Quarterly) stood at $129.9 million in 2020, then crashed by 92.79% to $9.4 million in 2021, then spiked by 1,035.32% to $106.4 million in 2022, then crashed by 76.51% to $25.0 million in 2023, then plummeted by 36.50% to $15.9 million in 2024.
  • Its last three reported values are $15.9 million in Q4 2024, -$31.4 million for Q3 2024, and -$21.6 million during Q2 2024.